1. Home
  2. BEP vs RGEN Comparison

BEP vs RGEN Comparison

Compare BEP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEP
  • RGEN
  • Stock Information
  • Founded
  • BEP 1999
  • RGEN 1981
  • Country
  • BEP Canada
  • RGEN United States
  • Employees
  • BEP N/A
  • RGEN N/A
  • Industry
  • BEP Electric Utilities: Central
  • RGEN Medical/Dental Instruments
  • Sector
  • BEP Utilities
  • RGEN Health Care
  • Exchange
  • BEP Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • BEP 7.0B
  • RGEN 6.6B
  • IPO Year
  • BEP N/A
  • RGEN N/A
  • Fundamental
  • Price
  • BEP $25.82
  • RGEN $118.91
  • Analyst Decision
  • BEP Buy
  • RGEN Buy
  • Analyst Count
  • BEP 8
  • RGEN 11
  • Target Price
  • BEP $31.25
  • RGEN $169.33
  • AVG Volume (30 Days)
  • BEP 459.3K
  • RGEN 995.5K
  • Earning Date
  • BEP 08-01-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • BEP 5.64%
  • RGEN N/A
  • EPS Growth
  • BEP N/A
  • RGEN N/A
  • EPS
  • BEP N/A
  • RGEN N/A
  • Revenue
  • BEP $6,174,000,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • BEP $17.39
  • RGEN $14.14
  • Revenue Next Year
  • BEP $4.42
  • RGEN $14.32
  • P/E Ratio
  • BEP N/A
  • RGEN N/A
  • Revenue Growth
  • BEP 15.23
  • RGEN 8.73
  • 52 Week Low
  • BEP $19.29
  • RGEN $102.97
  • 52 Week High
  • BEP $29.56
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • BEP 43.80
  • RGEN 46.10
  • Support Level
  • BEP $26.63
  • RGEN $119.03
  • Resistance Level
  • BEP $27.62
  • RGEN $132.24
  • Average True Range (ATR)
  • BEP 0.74
  • RGEN 5.12
  • MACD
  • BEP -0.13
  • RGEN 0.03
  • Stochastic Oscillator
  • BEP 5.53
  • RGEN 37.68

About BEP Brookfield Renewable Partners L.P.

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: